On 28 July 2017
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 28 July 2017, to approve the Unaudited Standalone Financial Results for the quarter ended on 30 June 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
